KRW 13080.0
(1.63%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 320.54 Billion KRW | 28.64% |
2022 | 249.18 Billion KRW | 31.58% |
2021 | 189.37 Billion KRW | -22.61% |
2020 | 244.71 Billion KRW | 166.36% |
2019 | 91.87 Billion KRW | 13.2% |
2018 | 81.16 Billion KRW | 2.97% |
2017 | 78.82 Billion KRW | 0.44% |
2016 | 78.47 Billion KRW | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 297.99 Billion KRW | -11.84% |
2024 Q1 | 338.01 Billion KRW | 5.45% |
2023 Q2 | 359.18 Billion KRW | -7.79% |
2023 Q4 | 320.54 Billion KRW | -7.9% |
2023 Q3 | 348.03 Billion KRW | -3.1% |
2023 Q1 | 389.51 Billion KRW | 56.32% |
2023 FY | 320.54 Billion KRW | 28.64% |
2022 Q4 | 249.18 Billion KRW | 9.0% |
2022 Q3 | 228.61 Billion KRW | -2.91% |
2022 Q2 | 235.45 Billion KRW | -1.19% |
2022 Q1 | 238.3 Billion KRW | 26.06% |
2021 Q4 | 189.03 Billion KRW | -3.15% |
2021 Q3 | 195.18 Billion KRW | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
InBody Co.,Ltd | 274.45 Billion KRW | -16.793% |
Curexo Inc. | 107.36 Billion KRW | -198.545% |
Seegene, Inc. | 1251.45 Billion KRW | 74.386% |
i-SENS, Inc. | 498.81 Billion KRW | 35.739% |
Ray Co., Ltd. | 259.55 Billion KRW | -23.5% |
Gencurix Inc. | 33.5 Billion KRW | -856.801% |
Sugentech Inc. | 133.18 Billion KRW | -140.674% |
L&C Bio Co., Ltd | 262.23 Billion KRW | -22.239% |